When multiple myeloma returns, choosing the right next-line therapy requires specialized expertise. A second opinion from a myeloma-focused center helps confirm your treatment plan, explore clinical trials, and access novel therapies like CAR-T. Key Takeaways Second opinions for relapsed myeloma are most valuable from dedicated myeloma programs at academic centers with high case volume and clinical trial portfolios US centers like Mayo Clinic, Dana-Farber, and Cleveland Clini

Relapsed multiple myeloma demands specialist expertise that goes beyond general oncology. Academic centers with dedicated myeloma programs offer access to clinical trials, advanced cytogenetic interpretation, and treatment-line sequencing strategies that can significantly impact outcomes. Key Takeaways Seek second opinions from dedicated myeloma programs at academic medical centers with specialists who actively participate in clinical trials and interpret cytogenetic markers